(cis-1-Benzylpyrrolidine-2,5-diyl)dimethanol

Catalog No. :
ACMHCG375
CAS No. :
269077-39-6
Molecular Formula :
C13H19NO2
Molecular Weight :
221.30

IUPAC Name:((2S,5R)-1-benzylpyrrolidine-2,5-diyl)dimethanol

(cis-1-Benzylpyrrolidine-2,5-diyl)dimethanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$258.00Login to see priceInquiryInquiry
250mg98%$614.00Login to see priceInquiryInquiry
1g98%$1535.00Login to see priceInquiryInquiry
5g98%$2898.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(cis-1-Benzylpyrrolidine-2,5-diyl)dimethanol
IUPAC Name((2S,5R)-1-benzylpyrrolidine-2,5-diyl)dimethanol
MDL No.MFCD17779280
Molecular FormulaC13H19NO2
Molecular Weight221.30
SMILESOC[C@H]1N(CC2=CC=CC=C2)[C@@H](CO)CC1
InChI KeyKDHJNPHFSBLEMM-BETUJISGSA-N
Synonym((2R,5S)-1-benzylpyrrolidine-2,5-diyl)dimethanol;(cis-1-Benzylpyrrolidine-2,5-diyl)diMethanol;[rel-(2R,5S)-1-benzyl-5-(hydroxymethyl)pyrrolidin-2-yl]methanol;2,5-Pyrrolidinedimethanol, 1-(phenylmethyl)-, (2R,5S)-rel-;cis-1-benzyl-5-(hydroxymethyl)pyrrolidin-2-yl]methanol
CAS No.269077-39-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMHCG375 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAUWB123 route compound structure diagram
    ACAUWB12352321-06-9 In Stock
  2. Then
  3. ACMHCG375 route product structure diagram
    ACMHCG375269077-39-6
Inquiry

2. ACMHCG375 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXDBY763 route compound structure diagram
    ACXDBY763113304-86-2 In Stock
  2. Then
  3. ACMHCG375 route product structure diagram
    ACMHCG375269077-39-6
Inquiry

Comments (0)